Upside Options Positioning in AstraZeneca (AZN) Continues -Susquehanna

Susquehanna options strategist Alison Edwards notes upside positioning in AstraZeneca (NYSE: AZN), as an opening investor bought 5k April 35 Calls for $1.80, following recent upside positioning via Dec 32.5, 35 & 37.5 Calls,

You May Also Be Interested In

• ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated statistically significant and clinically meaningful improvement in PFS as 1st-line treatment of patients with HER2-mutant advanced non-small ce
• Ross Stores (ROST) call put ratio 1.6 calls to 1 put into quarter results
• Bessent on Iran: maximum economic pressure means likely not a kinetic restart